Bluebird Bio Inc.
13F holders, Q4 2024 (December 31)3holders −136
0new positions
70sold out
$8.93avg. 13F price*
At the end of Q4 2024, 3 institutions reported holding Bluebird Bio Inc. in their 13F filings, down 136 from Q3 2024. 0 opened new positions and 70 sold out. The largest holders were IFP Advisors, Inc ($94K), Riggs Asset Managment Co. Inc. ($3K) and Raiffeisen Bank International AG ($972).
- Company
- Bluebird Bio Inc.
- CUSIP
- 09609G100
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 70 | $3.8M |
All 13F filers, Q3 2024 → Q4 2024: 7,324,491 shares sold, net −7,324,491 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| IFP Advisors, Inc | 0.00% | No change | 10,500 | $94K |
| Riggs Asset Managment Co. Inc. | 0.00% | Reduce -95.0% | 350 | $3K |
| Raiffeisen Bank International AG | 0.00% | — | 112 | $972 |
"% of holder's portfolio" is BLUEBIRD BIO INC's weight in each manager's 13F, not the share of Bluebird Bio Inc. the manager owns.